Aurélie Lefeuvre

Title: Aurélie Lefeuvre: Innovator in Influenza A Virus Detection

Introduction

Aurélie Lefeuvre is a notable inventor based in Grenoble, France. He has made significant contributions to the field of virology, particularly in the detection of the Influenza A virus. His innovative work has implications for public health and disease management.

Latest Patents

Lefeuvre holds a patent for "Oligonucleotides, use thereof, detecting method and kit for diagnosing the presence of H5 and N1 genes of the Influenza A virus." This invention involves a double pair of oligonucleotides designed to amplify two target sequences located in the H5 and N1 genes of the Influenza A virus genome. The oligonucleotides range in length from 10 to 50 nucleotides and include at least one fragment of 10 consecutive nucleotides derived from specific sequences. The invention also encompasses oligonucleotides for detecting amplicons, methods for detection, and a diagnostic kit for identifying the presence of H5 and N1 genes. This innovation is particularly applicable in the field of diagnosis.

Career Highlights

Throughout his career, Lefeuvre has worked with prominent companies in the biotechnology sector, including bioMérieux, Inc. and bioMérieux D.p.i. His experience in these organizations has contributed to his expertise in developing diagnostic tools for infectious diseases.

Collaborations

Lefeuvre has collaborated with notable colleagues such as Jean-Noel Telles and Guy Vernet. These partnerships have likely enhanced his research and development efforts in the field of virology.

Conclusion

Aurélie Lefeuvre's contributions to the detection of the Influenza A virus through innovative oligonucleotide technology highlight his role as a key inventor in the field. His work not only advances scientific knowledge but also has practical applications in public health diagnostics.